Skip to content

Acupuncture for Chemical Therapy Induced Nausea and Vomiting

Impact of Acupuncturist Expertise on Clinical Effectiveness for Chemotherapy Induced Nausea and Vomiting in Cancer Patients: a Randomized Controlled Trial

Status
Completed
Phases
NA
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT02842307
Enrollment
102
Registered
2016-07-22
Start date
2010-01-31
Completion date
2012-12-31
Last updated
2016-07-22

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Chemotherapy-induced Nausea and Vomiting

Keywords

Acupuncture, Expertise-based randomized controlled trial, Nausea, Vomiting, Cancer

Brief summary

This is an expertise-based randomized controlled trial. The hypothesis of this study is that the differences in expertise of acupuncturist may impact clinical effect. In this study, patients will be randomized to 4 group, receiving the treatment from senior acupuncturist, junior acupuncturist, junior acupuncturist by only acupuncture Neiguan(P6), or not receive the acupuncture. All patients receive the basic cisplatin chemotherapy. The duration of treatment is from the first day receiving cisplatin until two days after cisplatin on each group. NCI and Rhode scale will be used to measure the control of nausea and vomiting.

Detailed description

This is an expertise-based randomized controlled trial. The hypothesis of this study is that the differences in expertise of acupuncturist may impact clinical effect. In this study, 102 patients will be randomly divided into 4 groups which separately receiving the treatment from senior acupuncturist(clinical experience\> 15 years, considered in this trial as highly expertised), junior acupuncturist(clinical experience\< 5 years, considered in this trial as lower expertised), junior acupuncturist only acupuncture Neiguan(P6), or not receiving the acupuncture. All participants receive the cisplatin-based chemotherapy and 5-HT3 as antiemetic treatment will be included. Acupuncture treatments are given once daily, the duration of treatment is from the first day receiving cisplatin until two days after cisplatin. NCI and Rhode scale will be used to measure the control of nausea and vomiting. only outcome assessors are blinded. Generalized estimating equations will be used to compare the effects among groups.

Interventions

PROCEDUREManual acupuncture implemented by senior acupuncturists

Manual acupuncture once per day. No limitation on points, manipulations and time per session. Senior acupuncturists have to have more than 15 years of acupuncture clinical practice experience.

PROCEDUREManual acupuncture implemented by junior acupuncturists

Manual acupuncture once per day. No limitation on points, manipulations and time per session. Junior acupuncturists have to have less than 5 years of acupuncture clinical practice experience.

PROCEDUREManual acupuncture on P6 point

Manual acupuncture implemented by junior acupuncturists once per day. P6 point, bilaterally, should achieve deqi sensation by even manipulations. Junior acupuncturists have to have less than 5 years of acupuncture clinical practice experience.

Sponsors

Dongzhimen Hospital, Beijing
CollaboratorOTHER
Guang'anmen Hospital of China Academy of Chinese Medical Sciences
CollaboratorOTHER
Xiyuan Hospital of China Academy of Chinese Medical Sciences
CollaboratorOTHER
Beijing University of Chinese Medicine
Lead SponsorOTHER

Study design

Allocation
RANDOMIZED
Intervention model
PARALLEL
Primary purpose
TREATMENT
Masking
SINGLE (Outcomes Assessor)

Eligibility

Sex/Gender
ALL
Age
18 Years to No maximum
Healthy volunteers
No

Inclusion criteria

* Confirmed diagnosis of cancer * Must receive cancer chemotherapy containing cisplatin * Use 5-TH receptor antagonists as an antiemetic drug in the chemotherapy duration

Exclusion criteria

* Concurrent neoplasms or illness that induces nausea independent of chemotherapy * Received acupuncture treatments for other conditions less than 4 weeks before chemotherapy treatment * Severe infection * Severe heart, liver, kidney and brain diseases * Cardiac pacemaker * Radiotherapy or hormone therapy during chemotherapy treatments

Design outcomes

Primary

MeasureTime frame
NCI nausea and vomiting rating scaleFrom the first day receiving cisplatin until two days after cisplatin in each group
Rhodes ScaleFrom the first day receiving cisplatin until two days after cisplatin in each group

Secondary

MeasureTime frame
Consumption of additional antiemeticFrom the first day receiving cisplatin until two days after cisplatin
Patients' confidence towards acupuncture treatment (a single direct question with five levels of alternatives)The first day receiving cisplatin and the second day after cisplatin
Global assessment on effectiveness by patients (a single direct question with five levels of alternatives)The second day after cisplatin

Other

MeasureTime frame
Acupuncture related adverse eventsFrom the first day receiving cisplatin until two days after cisplatin
Adverse eventsFrom the first day receiving cisplatin until two days after cisplatin

Countries

China

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026